Barrett & Company’s Organon & Co OGN Stock Holding History

Barrett & Company’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$689	Sell	115 -6	-5%	-$45	﹤0.01%	621
2025 Q4	$867	Hold	121	–	–	﹤0.01%	622
2025 Q3	$1.29K	Sell	121 -14	-10%	-$137	﹤0.01%	601
2025 Q2	$1.31K	Sell	135 -32	-19%	-$330	﹤0.01%	600
2025 Q1	$2.49K	Sell	167 -21	-11%	-$323	﹤0.01%	544
2024 Q4	$2.81K	Sell	188 -4	-2%	-$65	﹤0.01%	534
2024 Q3	$3.67K	Sell	192 -48	-20%	-$995	﹤0.01%	507
2024 Q2	$4.97K	Sell	240 -28	-10%	-$556	﹤0.01%	489
2024 Q1	$5.04K	Sell	268 -50	-16%	-$858	﹤0.01%	489
2023 Q4	$4.59K	Sell	318 -59	-16%	-$803	﹤0.01%	478
2023 Q3	$6.54K	Sell	377 -3	-0.8%	-$63	﹤0.01%	459
2023 Q2	$7.91K	Sell	380 -26	-6%	-$565	﹤0.01%	430
2023 Q1	$9.55K	Sell	406 -54	-12%	-$1.45K	0.01%	389
2022 Q4	$12.8K	Hold	460	–	–	0.01%	361
2022 Q3	$12.8K	Buy	+460	New	+$13.9K	0.01%	361

Other funds holding OGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

KBG

Kahn Brothers Group New York $564M AUM 25.3% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PMG

Private Management Group Irvine, California $3.47B AUM 13.39% 1-Year Est. Return

Barrett & Company's OGN Position: Q1 2026 in Review

Barrett & Company reduced its Organon & Co (OGN) stake by 5% in Q1 2026, selling an estimated $45 and leaving 115 shares worth $689. The position accounts for ﹤0.01% of the portfolio, ranked #621.

Barrett & Company first reported a position in OGN in Q3 2022 and has held it in 15 quarters since. The position peaked at $12.8K in Q4 2022. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

Barrett & Company held 115 shares of Organon & Co worth $689 as of Q1 2026.
Barrett & Company sold 6 Organon & Co shares in Q1 2026, an estimated $45.
Organon & Co made up ﹤0.01% of Barrett & Company's portfolio in Q1 2026, its #621 holding.
Barrett & Company first reported a position in Organon & Co in Q3 2022 and has held it in 15 quarters since.
Barrett & Company's Organon & Co position peaked at $12.8K in Q4 2022.
603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Barrett & Company's 13F filing for Q1 2026, filed 4 May 2026.